Results 51 to 60 of about 172 (100)

Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response

open access: yesFrontiers in Immunology, 2019
The induction of specific and sustainable tolerance is a challenging issue in organ transplantation. The discovery of the immunosuppressive properties of apoptotic cells in animal models has paved the way for their use in human transplantation.
Caroline Pilon   +32 more
doaj   +1 more source

Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review

open access: yesJournal of Clinical Apheresis, Volume 39, Issue 6, December 2024.
ABSTRACT Scleromyxedema is a rare skin mucinosis often associated with systemic involvement and monoclonal gammopathy (MG). No formal recommendation for management with therapeutic plasma exchange (TPE) has been published due to rarity. This paper reports a 42‐year‐old male with progressive scleromyxedema.
Matthew H. Lanehart   +2 more
wiley   +1 more source

Robotic-assisted Ultrasound for Fetal Imaging: Evolution from Single-arm to Dual-arm System [PDF]

open access: yesarXiv, 2019
The development of robotic-assisted extracorporeal ultrasound systems has a long history and a number of projects have been proposed since the 1990s focusing on different technical aspects. These aim to resolve the deficiencies of on-site manual manipulation of hand-held ultrasound probes. This paper presents the recent ongoing developments of a series
arxiv  

Severe overlap of morphea and lichen sclerosus after anti‐PD‐L1 immunotherapy in small cell lung cancer

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 3, Page 378-380, March 2025.
Glenn Geidel   +7 more
wiley   +1 more source

Posttransplantation course after allogeneic stem cell transplantation in a patient with advanced mycosis fungoides—Balancing relapse and rejection

open access: yesJEADV Clinical Practice, Volume 3, Issue 5, Page 1660-1664, December 2024.
To date, the only potentially curative treatment option for advanced mycosis fungoides (MF) is allogeneic hematopoietic stem‐cell‐transplantation (alloHSCT). We report on a patient with MF who received allo‐HSCT due to rapid progression of the disease. Eight months after transplantation, relapse and chronic graft‐versus‐host‐disease occurred. Treatment
Inga Hansen‐Abeck   +5 more
wiley   +1 more source

A review on toxic epidermal necrolysis‐like superficial wound lesions: Issue and challenge on 10 clinical entities

open access: yesInternational Wound Journal, Volume 21, Issue 12, December 2024.
Abstract Toxic epidermal necrolysis (TEN) is a severe skin reaction caused by extensive epidermal and mucosal necrosis. This clinical phenomenon is known as an acute syndrome of apoptotic pan‐epidermolysis (ASAP). The ASAP phenomenon is observed in conditions that mimic TEN, highlighting the challenge in distinguishing these conditions.
Bahareh Abtahi‐Naeini   +3 more
wiley   +1 more source

A novel small molecule phagocytosis inhibitor, KB‐208, ameliorates ITP in mouse models with similar efficacy as IVIG

open access: yesTransfusion, Volume 64, Issue 12, Page 2233-2240, December 2024.
Abstract Background The characteristic feature of immune cytopenias involves the process of extravascular phagocytosis, wherein macrophages in the spleen and/or liver engage in the destruction of blood cells that have been opsonized by auto‐ or alloantibodies.
Melika Loriamini   +4 more
wiley   +1 more source

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

open access: yesExperimental Hematology & Oncology, 2012
We report the successful treatment and sustained molecular remission using single agent nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. Compared
Farnsworth Paul, Ward David, Reddy Vijay
doaj   +1 more source

Eliminating leukocyte reduction for whole blood: Is it premature to consider this paradigm‐changing practice?

open access: yes
Transfusion, Volume 65, Issue 2, Page 375-378, February 2025.
Brian D. Adkins   +12 more
wiley   +1 more source

Improving disease‐specific survival for patients with Sezary syndrome in the modern era of systemic therapies

open access: yesBritish Journal of Haematology, Volume 205, Issue 5, Page 1825-1829, November 2024.
Summary Traditionally, Sezary syndrome (SS) has been associated with few therapeutic options and poor prognosis, with 5‐year disease‐specific survival (DSS) less than one‐third in historical cohorts. However, newer therapies and combinations are associated with impressive time‐to‐next‐treatment (TTNT), particularly allogeneic stem‐cell transplantation (
Belinda A. Campbell   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy